First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Reaches New 12-Month High – What’s Next?

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)’s share price hit a new 52-week high during mid-day trading on Thursday. The stock traded as high as $44.19 and last traded at $43.8480, with a volume of 2,825 shares changing hands. The stock had previously closed at $43.25.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

The business’s 50-day moving average is $41.60 and its 200 day moving average is $37.09. The firm has a market capitalization of $1.16 billion, a P/E ratio of 14.51 and a beta of 0.45.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Thursday, September 24th were issued a dividend of $0.0113 per share. This is a decrease from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.0920. The ex-dividend date of this dividend was Thursday, September 24th. This represents a $0.05 dividend on an annualized basis and a dividend yield of 0.1%.

Institutional Trading of First Trust Nasdaq Pharmaceuticals ETF

Several institutional investors have recently added to or reduced their stakes in the stock. Oppenheimer & Co. Inc. acquired a new stake in First Trust Nasdaq Pharmaceuticals ETF during the third quarter worth approximately $6,014,000. D.A. Davidson & CO. bought a new stake in First Trust Nasdaq Pharmaceuticals ETF in the 3rd quarter worth about $3,702,000. Cyndeo Wealth Partners LLC bought a new position in First Trust Nasdaq Pharmaceuticals ETF in the 3rd quarter valued at $1,524,000. Trust Co. of Oklahoma purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 3rd quarter valued at $1,283,000. Finally, Nilsine Partners LLC boosted its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 3.5% in the 2nd quarter. Nilsine Partners LLC now owns 28,057 shares of the company’s stock worth $1,071,000 after buying an additional 937 shares during the last quarter.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.